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Abstract
Cobalamin (Cbl) utilization as a cofactor for methionine synthase and methylmalonyl-CoA mutase is
dependent on the transport of Cbl through lysosomes and its subsequent delivery to the cytosol and
mitochondria. We speculated that neuropathological conditions that impair lysosomal function (e.g., age-
related lipofuscinosis and specific neurodegenerative diseases) might impair lysosomal Cbl transport. To
address this question, an appropriate method to quantify intracellular Cbl transport in neuronal cell types and
brain tissue is required. Thus, we developed methods to measure [57Co] Cbl levels in lysosomes,
mitochondria and cytosol obtained from in vitro and in vivo sources. Human SH-SY5Y neurons or HT1080
fibroblasts were labeled with [57Co] Cbl and homogenized using a ball-bearing homogenizer, and the lysates
were separated into 10 fractions using ultracentrifugation in an OptiPrep density gradient. Lysosomes were
recovered from the top of the gradient (fractions 1-5), which were clearly separated from mitochondria
(fractions 7-9) on the basis of the expression of the marker proteins, LAMP2 and VDAC1. The isolated
lysosomes were intact based on their colocalization with acid phosphatase activity. The lysosomal and
mitochondrial fractions were free of the cytosolic markers beta-actin and methionine synthase. The relative
distribution of [57Co] Cbl in both neurons and fibroblasts was as follows: 6% in the lysosomes, 14% in the
mitochondria and 80% in the cytosol. This technique was also used to fractionate organelles from mouse
brain, where marker proteins were detected in the gradient at positions similar to those observed for the cell
lines, and the relative distribution of [57Co] Cbl was as follows: 12% in the lysosomes, 15% in the
mitochondria and 73% in the cytosol. These methods provide a useful tool for the investigation of intracellular
Cbl trafficking in a neurobiological setting.
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Cobalamin (Cbl) utilization as a cofactor for methionine synthase and methylmalonyl-CoA 
mutase is dependent on its transit through lysosomes and subsequent delivery to cytosol and 
mitochondria. We speculate that neuropathological conditions that impair lysosomal function 
(e.g. age-related lipofuscinosis and certain neurodegenerative diseases) may impair lysosomal 
Cbl transport. To study this question, an appropriate method to quantify intracellular Cbl 
transport in neuronal cell types and brain tissue is required. We therefore developed methods 
to measure [
57
Co]Cbl levels in lysosomes, mithochondria and cytosol derived from in vitro 
and in vivo sources. Human SH-SY5Y neurons or HT1080 fibroblasts were labelled with 
[
57
Co]Cbl, homogenised using a ball-bearing homogenizer, and the lysates separated into 10 
fractions using ultracentrifugation on an OptiPrep density gradient. Lysosomes were 
recovered at the top of the gradient (fractions 1 to 5) and were clearly separated from 
mitochondria (fractions 7 to 9) based on marker proteins LAMP2 and VDAC1, respectively. 
The isolated lysosomes were intact based on colocalisation with acid phosphatase activity. 
The lysosomal and mitochondrial fractions were free of cytosolic markers beta-actin and 
methionine synthase. The relative distribution of [
57
Co]Cbl in both neurons and fibroblasts 
was: lysosomes 6%, mitochondria 14% and cytosol 80%. The technique was also used to 
fractionate organelles from mouse brain where the marker proteins were detected in the 
gradient at similar positions to the cell lines and relative distribution of [
57
Co]Cbl was: 
lysosomes 12%, mitochondria 15% and cytosol 73%. These methods provide a useful tool for 




Abbreviations: AdoCbl, adenosyl cobalamin; Cbl, cobalamin, Hcy, homocysteine; LAMP2, 
lysosomal-associated membrane protein 2; LER, Lysosome Enrichment Reagent; Met, 
methionine; MS, methionine synthase; MeCbl, methyl Cbl; MMCM, methylmalonyl-
coenzyme A mutase; 5-methyl-THF, 5-methyltetrahydrofolate; THF, tetrahydrofolate; 






 is required for erythrocyte formation and DNA synthesis, and plays a 
crucial role in the maintenance of neurological function. Methyl Cbl (MeCbl) and adenosyl 
Cbl (AdoCbl) are the forms that are active in human metabolism. These two forms of Cbl 
differ only in the functional group attached to the Co atom at the centre of the Cbl corrin ring. 
MeCbl is used to transform homocysteine (Hcy) to methionine (Met) via cytosolic 
methionine synthase (MS). This reaction requires donation of a methyl group derived from 
the transformation of 5-methyltetrahydrofolate (5-methyl-THF) to tetrahydrofolate (THF). 
Through the action of methionine adenosyltransferase, Met is utilized in the formation of S-
adenosylmethionine (SAM), a universal methyl donor for numerous substrates, including 
DNA, RNA, hormones, proteins, and lipids. AdoCbl is required for the conversion of 
methylmalonyl-coenzyme A (Mm-CoA) to succinyl-coenzyme A (Succ-CoA) via 
mitochondrial Mm-CoA mutase (MMCM). Succ-CoA then enters the Krebs cycle, after 
which it may be utilized in many pathways including conversion to succinate which may be 
used as an electron donor or in the synthesis of porphyrins such as haeme. 
 
MS and MMCM activities are reduced in human Cbl deficiency states, causing increased 
tissue and plasma Hcy levels and, subsequent to the conversion of Mm-CoA to 
methylmalonic acid (MMA), increased tissue and plasma MMA levels. Because of the roles 
of both MS and MMCM in methylation reactions and multiple pathways related to, for 
example, amino acid and lipid metabolism, the clinical Cbl deficiency phenotypes are 
multifaceted (Baik and Russell, 1999). In addition to the “loss of function” caused by 
impaired MS and MMCM activities, the accumulation of Hcy and MMA is neurotoxic and is 




Cbl utilization is dependent on its transit through the intracellular lysosomal compartment 
(Banerjee et al., 2009; Gailus et al., 2010; Zhao et al., 2011). We have recently proposed that 
pathophysiological impairment of lysosomal functions that occur in various conditions such 
as Alzheimer’s disease, lysosomal storage disorders and in age-related neuronal 
lipofuscinosis may form a “road block” for efficient Cbl utilization in cells. We predict that 
these conditions may impair the release Cbl from its carrier protein transcobalamin-II (TCII) 
and inhibit the transport of lysosomal Cbl to both MS and MMCM (Zhao et al., 2011). In 
addition, it is known that the acidic pH of the lysosome also influences the conversion of Cbl 
from the “base-on” to “base-off” state, which refers to the interaction of the 
dimethylbenzimidazole moiety of the Cbl molecule with the central Co atom (Banerjee, 
2006). The Cbl base-off state is thought to be important for subsequent interactions with 
cytosolic cargo proteins. 
 
In order to accurately assess the trafficking of Cbl through the lysosomal compartment it is 
necessary to establish subcellular fractionation methods that clearly separate lysosomes from 
the intracellular compartments that contain MS and MMCM, i.e. the cytosol and 
mitochondria, respectively. The aim of the current experiments was therefore to develop 
subcellular fractionation methods whereby cells and brain tissues could be metabolically 
labeled with [
57
Co]Cbl in order to quantify Cbl distribution between lysosomes, mitochondria 
and cytosol. 
 
2. Materials and methods 
  
2.1. Cell culture 
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Experiments were performed using human neuroblastoma cells (SH-SY5Y, ATCC #CRL-
2266) and human fibrosarcoma cells (HT1080, ATCC #CCL-121) obtained from the 
American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in 
DMEM supplemented with 10% fetal calf serum, 1% penicillin/streptomycin, and 1% 
glutamine, at 37˚C in a humidified atmosphere containing 5% CO2. Cells were grown in four 
175 cm
2
 plastic flasks until approximately 70% confluent, when cells were incubated with 
[
57
Co]cyanoCbl (0.025 Ci/ml; Cat. No. 06B-430002, MP Biomedicals, USA) in DMEM  
with 10% human serum and 1% penicillin/streptomycin and 1% glutamine for 48 h. The cells 
were then rinsed with cold (10˚C) PBS and harvested with 1% trypsin, and centrifuged at 600 
g for 5 min at 4˚C. A small portion of the cells was stained with 0.5% trypan blue to 
determine the number of viable cells. 
 
2.2. Cell homogenization 
 
A lysosome enrichment kit (Pierce, Cat #89839, USA) was applied to perform subcellular 
fractionation. An 800 μl aliquot of extraction buffer Lysosome Enrichment Reagent (LER) 
“A” containing 1% protease inhibitors was added to the cell pellets. The pellets were gently 
re-suspended and incubated on ice for no more than 2 minutes. The cell suspension was 
transferred to a ball-bearing cell homogenizer (Isobiotec, Germany) and homogenized on ice. 
To check lysis efficiency, 10 μl of cell lysate was stained with 0.5% trypan blue and viewed 
under a light microscope. Homogenization was continued until 95% cell membrane breakage 
was achieved (typically 10 to 15 passages through the homogenizer). Next, the lysed cells 
were transferred into a 2 ml microcentrifuge tube and 800 μl of LER “B” containing 1% 
protease inhibitors was mixed with the lysed cells. The mixed cell lysates were centrifuged at 
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600 g for 10 min at 4˚C to remove nuclei and membranous debris and the supernatant (1500 
l) containing lysosomes, mitochondria and cytosol was collected. 
 
2.3. Density gradient ultracentrifugation 
 
To prepare a discontinuous density gradient, five gradient solutions were prepared by mixing 
gradient dilution buffer (a 1:1 mixture of LER A and LER B) with the OptiPrep medium (that 
is supplied as a 60% solution in H2O) as described in Table 1. The diluted OptiPrep density 
gradient solutions were carefully overlayed in descending concentration order (i.e. 30% 
OptiPrep solution first and then 27%, 23%, 20% and 17%) in a 7 ml ultracentrifuge tube 
(Hitachi Koki, Japan). Next, the prepared 1500 μl supernatants from the cell extracts 
described above were mixed with 500 μl of OptiPrep medium to make a final concentration 
of 15% OptiPrep and this was overlayed on the top of the density gradient. The tube was 
centrifuged at 145,000 g for 4 h at 4˚C using a Sorvall MTX 150 ultracentrifuge and a Sorvall 
S50ST swinging bucket rotor (Thermo Scientific). After centrifugation, two distinct bands 
appeared in the gradient solution (Fig. 1). 
 
A total of 10 fractions of 600 μl each were carefully withdrawn from the top of the gradients 
using extra long micropipette tips (Finntip 200, Thermo Scientific). The amount of [
57
Co]Cbl 
in each fraction was measured by a Wallace Gamma Counter (PerkinElmer, Finland). Next, 
each isolated fraction was mixed with 1000 μl PBS and centrifuged at 20,000 g for 30 min at 
4˚C to separate lysosomes and mitochondria from cytosol. After centrifugation, the 
supernatant of each fraction was collected and labeled as cytosolic fractions; while the pellets 
from each fraction were mixed with 400 μl PBS and labeled as lysosomal and mitochondrial 
fractions (subsequent to identification of organelle markers by western blotting as described 
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below). Both the pellet and supernatant fractions were assessed for [
57
Co]Cbl radioactivity 
and organelle markers. An overview of the procedure is illustrated in Figure 1. 
 
2.4. Western blotting 
 
To identify the fractions containing lysosomes, mitochondria, and cytosol, western blotting 
was performed with appropriate antibodies to marker proteins; lysosome, lysosomal-
associated membrane protein 2 (LAMP2, Southern Biotech); mitochondria, voltage-
dependent anion channel 1 (VDAC1, Abcam); cytosol, β-actin (Sigma) and methionine 
synthase / 5-methyltetrahydrofolate-homocysteine methyltransferase (MS, Abnova). Briefly, 
sample proteins from each fraction were separated on 12% SDS PAGE gels using a Mini-
Protean II system (Bio-Rad) at 150 V for 70 minutes followed by transfer at 100 V for 30 
min onto 0.45 m nitrocellulose membranes using a Mini-Trans-Blot Electrophorectic 
Transfer cell (Bio-Rad). The membranes were blocked in 5% (w/v) non-fat milk powder in 
PBS for 1 h at 22˚C and then probed with anti-LAMP2 mouse monoclonal antibody (1:4000), 
anti-VDAC1 rabbit polyclonal antibody (1:4000), anti-β-actin rabbit polyclonal antibody 
(1:10000), and anti-MS goat polyclonal antibody (1:300) at 4°C for 16 h, followed by 
incubation with the appropriate horseradish-peroxidase-conjugated rabbit anti-mouse 
(1:4000, Dako), goat anti-rabbit (1:4000, Dako), and rabbit anti-goat (1:4000, Dako) IgG 
antibodies for 1 h at 22˚C. Blots were rinsed in PBS and proteins were detected using 
enhanced chemiluminescence (ECL, Amersham Biosciences). The membranes were exposed 
to X-ray film (Fuji), developed, scanned and signal intensity was quantified using NIH Image 
software. 
 
2.5. Acid phosphatase assay 
 9 
 
During cell homogenization and ultracentrifugation, lysosome membranes are susceptible to 
pressure and may be broken, thus lysosomal hydrolases may be leaked into the cytosol as a 
consequence. Acid phosphatase is one of the acid hydrolases that exist in lysosomes and 
therefore is a classical marker for the identification of lysosomes in subcellular fractionation 
studies. The acid phosphatase assay kit (Sigma, Cat #CS0740) was applied to detect 
lysosome membrane integrity in each fraction. Briefly, a substrate solution was prepared by 
dissolving one 4-nitrophenyl phosphate tablet in 5 ml of citrate buffer and the solution 
equilibrated at 37˚C. The standard solution was prepared by diluting 5 µl of the 10 mM 
nitrophenol standard solution in 995 µl of 0.5 M NaOH. The reaction components and 
samples were added to 96-well microtitre plates according to the manufacturer’s instructions 
and samples analysed in triplicate. The plate was incubated for 10 min at 37˚C after which 
time 200 µl of 0.5 M NaOH was added to all wells (except the standard) to stop the reaction. 
Absorption was measured at 405 nm using a microtitre plate reader (Spectra Max, Bio 
Strategy) and results expressed as acid phosphatase Units / ml (where 1 Unit of enzyme 
activity will hydrolyse 1 mole of 4-nitrophenyl phosphate per min at pH 4.8 at 37˚C). 
 
2.6. Animal study 
 
To examine the subcellar distribution of [
57
Co]Cbl in lysosomes, mitochondria, and cytosol 
derived from the brain, an in vivo study was carried out using two 12-month old male wild-
type C57Bl/6J mouse. This study was approved by the University of Wollongong Animal 
Ethics Committee and was carried out in accordance with EU Directive 2010/63/EU for 
animal experiments. The mice were intraperitoneally injected with 4 Ci [
57
Co]cyanoCbl in a 
volume of 0.2 ml sterile saline (0.9% w/v NaCl). The mice were weighed at time of injection 
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and again just before sacrifice. After 72 h the mice were sacrificed and the blood samples 
were collected by cardiac puncture. The mice were then transcardially perfused with PBS and 
the brain, liver and kidney were dissected. All organs were weighed and the amount of 
[
57
Co]Cbl in these organs was measured using a gamma counter. In this experiment, only the 
brain was used for organelle isolation. The brain was rinsed with PBS and cut into small 
pieces (< 3 mm
3
). The procedures for homogenization and subcellular fractionation were the 
same as described above for cultured cells. 
 
2.7. Data analysis 
Data are presented as mean ± SE of three independent experiments unless stated otherwise. 
Note that the results for [
57
Co]Cbl are presented as counts per minute (cpm). The radioactive 
tracer molecule [
57
Co]cyanoCbl was provided by the supplier in batches of 10.5 Ci in a 
volume of 1 ml H2O containing 0.9% (vol/vol) benzyl alcohol. On the reference date 
provided by the manufacturer, 0.1 ml from each batch of [
57
Co]cyanoCbl yielded 2.0 x 10
6
 
cpm. After evaporation to dryness and reconstitution in cell culture medium (or saline for i.p. 
injection), the [
57
Co]cyanoCbl radioactivity was measured in a 0.1 ml aliquot to confirm 
radioactivity before use in all experiments. For the experiments described herein, the 
[
57
Co]cyanoCbl tracer was routinely used within 2 months of the reference date and the 
radioactivity per 0.1 ml on the day of preparation for addition to cells or animals was 1.52 x 
10
6
 + 0.04 x 10
6
 cpm (mean + SE, n = 8). The values ranged form 1.37 x 10
6
 - 1.65 x 10
6
 cpm 
in these experiments. As an approximation, based on a specific activity for [
57
Co]cyanoCbl of 
300 Ci / g, at the time of use in experiments 1000 cpm equates to ~ 2.4 pg of [
57
Co]Cbl. It 
should be noted that in two months the radioactivity of 
57
Co has decreased by 14% and this 





3.1. Method overview 
 
Cbl exists in three main compartments in the cell: the lysosome, mitochondria and cytosol. In 
order to accurately assess Cbl transit through intracellular compartments, it is essential to 
develop methods that can separate at least these three compartments into fractions in which 
labeled Cbl can be unambiguously quantified. We therefore used the following steps to 
achieve this: (1) cells were labeled with [
57
Co]Cbl; (2) cells were disrupted in a ball-bearing 
homegnizer, (3) the isolated organelles were separated from cellular membrane debris and 
nuclei, (4) the organelles were separated over an OptiPrep density gradient by 
ultracentrifugation, (5) ten fractions were collected from the gradient, and (6) the fractions 
were separated into pellet (organelle) and supernatant (cytosol) fractions. The methodological 
detail for each of these steps is described in “Materials and Methods” and an overview is 
illustrated in Figure 1. The purified fractions were then analysed for various organelle 




3.2. Isolation of lysosomes, mitochondria and cytosol from fibroblasts 
 
Our initial experiments focused on the HT1080 human fibroblast cell line. Western blot 
analysis of the organelle fractions for LAMP2 and VDAC1 (lysosomal and mitochondrial 
markers, respectively) revealed lysosomes were recovered from the top of the OptiPrep 
gradient, especially in Fraction 1 (Fig. 2A). As LAMP2 was also detected at lower levels in 
Fractions 2 to 5, these fractions together (Fractions 1 to 5) were considered to represent the 
lysosomal content of the cells. In contrast, VDAC1 was detected in Fractions 7 to 9 and thus 
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represented the mitochondrial fractions. It is noteworthy that -actin was detected at very low 
levels, if at all, in the isolated organelle fractions, and MS was not detected in any of the 
organelle fractions (Fig. 2A). This indicates that pure lysosomes can be separated from 
mitochondria and that both organelles are essentially free of cytosolic contaminants that may 
spuriously contribute to apparent organelle Cbl levels. 
 
The cytosolic components of each of the ten OpitPrep gradient fractions were also assessed 
by western blotting. Neither LAMP2 nor VDAC1 were detected in the cytosolic fractions, 
whereas -actin was clearly detected in Fractions 1 to 8, with particularly high levels in 
Fractions 1 to 4 (Fig. 2B). In addition, MS was detected in Fractions 1 to 3, with particularly 
high levels in Fraction 2. 
 
3.3. Isolation of lysosomes, mitochondria and cytosol from neurons 
We also used the same method to purify lysosomes and mitochondria from the human SH-
SY5Y neuronal cell line. Similar to the results derived from our fibroblast studies, pure 
lysosomal and mitochondrial preparations were recovered from Fractions 1 to 5 and from 
Fractions 7 to 9, respectively (Fig. 3A). Neither -actin nor MS were detected in the 
organelle fractions (Fig 3A). Assessment of the cytosolic fractions revealed there was no 
contamination of cytosol with lysosomes or mitochondria, as assessed by lack of signal for 
LAMP2 and VDAC1, respectively (Fig. 3B). Moreover, -actin was clearly detected in 
Fractions 1 to 9, with particularly high levels in Fractions 1 to 6, whereas MS was detected in 
predominantly Fractions 2 to 5 (Fig. 3B). 
 
The methods we describe can therefore be used to isolate pure lysosomal, mitochondrial and 
cytosolic preparations from fibroblasts and neurons. 
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3.4. Confirmation that isolated lysosomes remain intact after purification 
 
To confirm that the isolated lysosomes remained intact during the homogenization and 
ultracentrifugation procedures, we assessed all organelle and cytosolic fractions for acid 
phosphatase activity. The data indicate that acid phosphatase activity correlated with the 
expression of LAMP2 in the lysosomal fractions from both fibroblasts and neurons (Fig 4A 
and 4B, respectively). Furthermore, acid phosphatase activity was not detected in any of the 
cytosolic fractions (Fig 4). This indicates that lysosomes remain structurally intact during the 
isolation procedures and that the lysosomal membranes are not compromised. Note that the 
buffers used in the acid phosphatase assay were adjusted to pH 4.8 so that even if the enzyme 
was located in the cytosol (normally close to neutral pH) we would still detect its activity in 




Co]cobalamin distribution in fibroblasts and neurons 
 
Having established methods for the isolation of pure lysosomes, mitochondria and cytosol, 
and shown that the lysosomes maintain their structural integrity, we next assessed the 
subcellular distribution of [
57
Co]Cbl in the both fibroblasts and neurons subsequent to 
metabolic radiolabeling. 
 
Our pilot studies indicated that [
57
Co]Cbl labeling required 0.025 Ci [
57
Co] / ml of growth 
medium for a 48 h incubation period. We observed that the use of either bovine serum or 
heat-inactivated human serum substantially reduced the incorporation of [
57
Co]Cbl into cells 
(H. Zhao and B. Garner, unpublished observations). After the 48 h labeling period, 24.2 + 
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1.3% of the radioactivity was incorporated into the fibroblasts (mean + SE, n=3). 
Interestingly, under the same culture conditions only 6.9 + 1.5% of the radioactivity was 
incorporated into the neurons (mean + SE, n=3). Despite the relatively low level of isotope 
incorporation, this was clearly sufficient to assess [
57
Co]Cbl distribution in lysosomes, 
mitochondria and cytosol. The data presented in Figure 5A indicate that for fibroblasts, the 
relative distribution of [
57
Co]Cbl was: lysosomes 5.8 + 0.2%, mitochondria 14.0 + 0.7% and 
cytosol 80.2 + 0.9% (all mean + SE, n=3). The corresponding data for neurons was: 
lysosomes 5.1 + 0.3%, mitochondria 13.3 + 0.6% and cytosol 81.6 + 0.8% (all mean + SE, 
n=3). Even though we observed a degree of variability in the absolute CPM values for 
[
57
Co]Cbl in each of the fractions assessed over three independent experiments (Fig 5B), the 
proportional distribution of [
57
Co]Cbl in the intracellular compartments was remarkably 




Co]cobalamin distribution in lysosomes, mitochondria and cytosol from 
brain 
 
In a final series of experiments, we assessed if the subcellular fractionation methods utilized 
above could also be applied to study [
57
Co]Cbl distribution in lysosomes, mitochondria and 
cytosol isolated from mouse brain. Two male C57Bl/6J mice were injected intraperitoneally 
with 3 Ci [
57
Co]Cbl. After 72 h the mice were euthanased, perfused with PBS, and the 
major organs (listed below) were carefully dissected. The distribution of radioactivity in the 
whole organs collected from the two mice was: brain 13,200 – 14,000 cpm, liver 354,000 - 
412,000 cpm, kidney 316,000 – 545,000 cpm, heart 8,100 – 8,500, spleen 11,000 – 14,600 
cpm (individual values shown, n=2). The radioactivity in plasma was 117,000 – 128,000 cpm 
per 100 l (individual values shown, n=2), and in faeces was 340,000 cpm (total value and 
 15 
only collected in one experiment). A total of 32% of the injected [
57
Co]Cbl radioactivity was 
recovered in these samples. The relative ratio of [
57
Co]Cbl recovered in the whole organs 
was: brain 1 : liver 28 : kidney 32 : heart 0.6 : spleen 1. 
 
We then subjected the whole brain to the subcellular fractionation method developed above. 
Highly purified lysosomal and mitochondrial preparations that were essentially free of -
actin were recovered from Fractions 1 to 4 and from Fractions 7 to 9, respectively (Fig. 6A). 
Analysis of the mouse brain cytosolic fractions indicated a strong signal for -actin in 
Fractions 1 to 5 and no contamination with either LAMP2 or VDAC1 (Fig. 6B). Similar to 
the data derived from cultured cells, acid phosphatase activity colocalised predominatly in the 
LAMP2-positive fractions (Fig. 6C). Finally, the relative distribution of [
57
Co]Cbl in the 
organelle fractions derived from the brain was measured and found to be: lysosomes 215 (5) 
cpm, mitochondria 290 (25) cpm and cytosol 1295 (35) cpm (mean values with range shown 
in parentheses). The corresponding relative percentage distribution values were therefore 




In the present work we have successfully developed a [
57
Co]Cbl metabolic labeling / 
subcellular fractionation method that permits the separation of the two major pools of 
intracellular Cbl (in the cytosol and mitochondria) from the presumably more transient 
lysosomal pool. This methodology builds on many previous studies that have separately 
analysed cellular [
57
Co]Cbl metabolism in cells and mice (Hannibal et al., 2008; Mellman et 
al., 1978; Yamani et al., 2008; Yassin et al., 2000; Youngdahl-Turner et al., 1978) or aspects 
of lysosome function in cells and mice (Manunta et al., 2007; Yang et al., 2011). Our data 
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derived from fibroblast and neuronal cell lines indicates that under steady-state conditions, 
only ~6% of cellular [
57
Co]Cbl resides in the lysosome. This is perhaps not surprising based 
on the fact that the major sites of Cbl utilization in humans are the enzymes MS and MMCM 
located in the mitochondria and cytosol respectively. We also showed that the subcellular 
fractionation methods could be used to assess lysosomal [
57
Co]Cbl content in mouse brain. In 
this case ~12% of cellular [
57
Co]Cbl was detected in the lysosome and this was similar to the 
amount in mitochondria (~15%). It is currently not clear why lysosomes isolated from the 
brain are apparently enriched in [
57
Co]Cbl as compared to the cell lines. We were unable to 
measure mouse MS by western blotting so it is possible that traces of cytosolic contamination 
in these fractions could contribute to the cpm values; although the very low levels of -actin 
contamination would argue against this. Further rinse steps after the OptiPrep gradient (see 
Fig 1) may improve organelle purity; however, the challenge with the brain analysis is the 
relatively low amount of [
57
Co]Cbl incorporation and the possibility that further rinsing may 
reduce recovery of the lysosomes. In the brain subcellular fractionation experiments, much 
more material was loaded onto the OptiPrep gradient (e.g. the lysosomal acid phosphatase 
activity is 10-fold higher than for the neuronal cell line (compare Fig. 3B and Fig. 6C) and it 
is possible that analysis of a smaller fraction of the brain tissue would alter the recovery of 
organelles through the fractions. Again, though, this would reduce the amount of [
57
Co]Cbl 
that could be detected in the fractions. Future studies could adapt the methods we have 
established to investigate lysosomal [
57
Co]Cbl distribution in brain tissues from other species 
and in mouse models of ageing and neurodegenerative disease. 
 
We also noted that in the subcellular fractionation of the brain tissue, a small increase in acid 
phosphatase activity was present with the major mitochondrial fraction (Fraction 8). We did 
not detect LAMP2 in this fraction so lysosomal contamination seems unlikely. One possible 
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explanation could be that one or more of the several known mitochondrial phosphatases may 
have residual activity at pH 4.8 and thus act upon the 4-NPP is our assay (McBride et al., 
2006). 
 
The critical role that the lysosome plays in delivery of Cbl to MS in the cytosol and MMCM 
in the mitochondrion is demonstrated by the inborn error of Cbl metabolism referred to as 
cblF. This life-threatening condition is caused by defects in the LMBRD1 gene that encodes 
LMBD1 (Rutsch et al., 2009). The defect in lysosomal Cbl release was discovered 25 years 
ago, well before the likely transporter involved was characterised (Rosenblatt et al., 1985). 
These pioneering studies also showed that chloroquine, a compound that increases lysosomal 
pH above its physiological level of ~ 4.5 thereby inhibiting lysosomal protease activity, 
prevents the release of Cbl from TCII and blocks the transport of lysosomal [
57
Co]Cbl to both 
MS and MMCM (Rosenblatt et al., 1985). We have recently hypothesized that in addition to 
LMBRD1 mutations and drug-mediated alterations of lysosomal function that may trap Cbl in 
the lysosome, additional pathophysiological perturbations in lysosome function could also 
represent a “roadblock” for Cbl transit through the lysosomal compartment (Zhao et al., 
2011). Future studies could utilize the methods we have established herein to assess cell lines 
and animals models that are known to have impaired lysosome function due to, for example, 
accumulation of the age pigment lipofuscin, substrate accumulation in various lysosomal 
storage diseases, or accumulation of -amyloid (Zhao et al., 2011). Based on the fact that Cbl 
deficiency includes a neurological phenotype (Baik and Russell, 1999; Calvaresi and Bryan, 
2001; Healton et al., 1991) we focused on brain tissue in the in vivo aspect of the present 
study. There is no reason why the techniques could not be employed to study other tissues in 
animal studies and we predict (based on the much higher [
57
Co]Cbl levels recovered in the 
liver and kidney, that the injected [
57
Co]Cbl dose could be reduced at least 10-fold. Finally, 
 18 
although we have chosen to use commercially available reagents for some of the subcellular 
fractionation steps, it is likely that buffer compositions that have been published (e.g. 
(Graham, 2001; Koenig, 1974; Yamada et al., 1984)) may yield similar results. 
 
5. Conclusions 
We have established a subcellular fractionation method that provides a useful tool for 
investigating intracellular [
57
Co]Cbl trafficking. The method can be applied to both neuronal 
and fibroblast cell lines and in brain tissues and may be adapted to study the impact that 
pathophysiological impairment of lysosomal function has on intracellular [
57
Co]Cbl transport 
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Fig. 1. Overview of [
57
Co]Cbl labelling and subcellular fractionation procedures. Cells were 
incubated with 0.025 Ci/ml [
57
Co]cyanoCbl in DMEM with 10% (v/v) human serum at 
37˚C for 48 h. The cells were then homogenized in a ball-bearing homogenizer to disrupt the 
plasma membrane. Membrane debris and nuclei were removed by centrifugation at 600 g for 
10 min and the supernatant samples overlayed at the top of an OpitPrep density gradient. 
After ultracentrifugation at 145,000 g for 4 h, a total 10 fractions of 600 μl each were 
collected and the lysosomal/mitochondrial fractions separated from the cytosol by mixing 
with PBS followed by further centrifugation at 20,000 g for 30 min. The organelle and 





Fig. 2. Separation of lysosomes, mitochondria, and cytosol in HT1080 fibroblast fractions. 
Approximately 16 x 10
6
 cells were metabolically labelled with [
57
Co]Cbl for 48 h. The 
radiolabelled cells were disrupted using a ball-bearing homogeniser and the lysosomes, 
mitochondria, and cytosol fractions were separated using an OptiPrep gradient. The 
appearance of the markers LAMP2 (lysosomal), VDAC1 (mitochondrial), β-actin and MS 
(both cytosolic) were then probed by wester blotting in all fractions (note Fraction 1 is the 
least dense from the top of the gradient). (A) In the pellet fractions, a clear separation could 
be seen for lysosomes (fractions 1 to 5) and mitochondria (fractions 7 to 9). Cytosolic 
markers were either absent or present only at trace amounts. (B) In the supernatant portion of 
the fractions, lysosomal, mitochondrial markers were not detected, however, strong signals 
for cytosolic markers β-actin (fractions 1 to 8) and MS (fractions 1 to 2) were detected. Data 
are representative of three independent experiments. 
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Fig. 3. Separation of lysosomes, mitochondria, and cytosol in SH-SY5Y neuron fractions. 
Approximately 16 x 10
6
 cells were metabolically labelled with [
57
Co]Cbl for 48 h. The 
radiolabelled cells were disrupted using a ball-bearing homogeniser and the lysosomes, 
mitochondria, and cytosol fractions were separated using an OptiPrep gradient. The 
appearance of the markers LAMP2 (lysosomal), VDAC1 (mitochondrial), β-actin and MS 
(both cytosolic) were then probed by wester blotting in all fractions (note fraction 1 is the 
least dense from the top of the gradient). (A) In the pellet fractions, a clear separation could 
be seen for lysosomes (fractions 1 to 5) and mitochondria (fractions 7 to 9). Cytosolic 
markers were absent. (B) In the supernatant portion of the fractions, lysosomal, mitochondrial 
markers were not detected, however, strong signals for cytosolic markers β-actin (fractions 1 
to 8) and MS (fractions 2 to 5) were detected. Data are representative of three independent 
experiments. 
 
Fig. 4. Acid phosphatase activity in HT1080 fibroblast and SH-SY5Y neuron fractions. 
Approximately 16 x 10
6
 cells were disrupted and fractionated using an OptiPrep gradient as 
described in the Legend to Fig. 2. Acid phosphatase activity (indicating the presence of 
lysosomes with an intact membrane) was measured in all pellet fractions (circles) and 
cytosolic fractions (squares) using 4-nitrophenyl phosphate (4-NPP) as a colorimetric 
substrate. Acid phosphatase activity in HT1080 fibroblast fractions (A) and SH-SY5Y neuron 
fractions (B) indicate that lysosomes are predominantly found at the top of the density 
gradient (fraction 1) and are structurally intact (high acid phosphatase activity). Acid 
phosphatase activity in the supernatant fractions was negligible. 
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Fig. 5. Distribution of [
57
Co]Cbl in lysosomes, mitochondria, and cytosol derived from 
HT1080 fibroblasts and SH-SY5Y neurons. Approximately 16 x 10
6
 cells were metabolically 
labelled with [
57
Co]Cbl for 48 h. The radiolabelled cells were disrupted using a ball-bearing 
homogeniser and the lysosomes, mitochondria, and cytosol fractions were separated using an 
OptiPrep gradient. (A) The proportional distribution of [
57
Co]Cbl was assessed using a 
gamma counter and expressed as a percentage of radioactvoty in each fraction for both cell 
types. Data are means with SE represented by the error bars (n=3 experiments for each cell 
type). L, lysosome; M, mitochondria; C, cytosol. (B) The cpm data for each of the fractions 
in three independent experiments performed for each cell type shown in “A” is provided. 
 
Fig. 6. Isolation and characterisation of lysosomes, mitochondria, and cytosol derived from 
mouse brain. A 12-month old male C57Bl/6J mouse was injected intraperitoneally with 3 Ci 
[
57
Co]Cbl and after 72 h the mouse was euthanased, perfused, and the brain was 
homogenised using a ball-bearing homogeniser. The lysosomes, mitochondria, and cytosol 
fractions were then separated using an OptiPrep gradient. (A) In the pellet fractions, a clear 
separation could be seen for lysosomes (fractions 1 to 3) and mitochondria (fractions 6 – 9) 
based on LAMP2 and VDAC1 levels, respectively. The cytosolic marker, -actin, was either 
absent or present only at trace amounts. (B) In the supernatant portion of the fractions, 
lysosomal and mitochondrial markers were not detected, however, a strong signal for 
cytosolic marker β-actin (fractions 1 to 5) was detected. (C) Acid phosphatase activity 
(indicating the presence of lysosomes with an intact membrane) was measured in all pellet 
fractions (circles) and cytosolic fractions (squares) using 4-nitrophenyl phosphate (4-NPP) as 
a colorimetric substrate. Acid phosphatase activity indicates that lysosomes are 
predominantly found at the top of the density gradient (fraction 1) and are structurally intact 
(high acid phosphatase activity). Acid phosphatase activity in the supernatant fractions was 
 25 
negligible. (D) The proportional distribution of [
57
Co]Cbl was assessed using a gamma 
counter and expressed as a percentage of radioactivity in each fraction. L, lysosome; M, 
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